At interim analysis, overwhelming efficacy necessitated stopping the trial for ethical considerations:
389 people who got Paxlovid: 3 hospitalizations, 0 deaths
385 people who got placebo: 27 hospitalizations, 7 deathshttps://t.co/YiZM8qi0bg @Carolynyjohnson pic.twitter.com/k4HueNjJx4

— Eric Topol (@EricTopol) November 5, 2021